St Helier A&E 'at breaking point' and is among London's worst for wait times
Bobby Dean MP believes the Sutton hospital has reached a 'breaking point' as the Trust has been named one of the worst-performing NHS trusts in London in terms of A&E wait times.
Research commissioned by the Liberal Democrats revealed that more than 34 per cent of patients had to wait more than 12 hours to be admitted to A&E at Epsom and St Helier Trust.
St Helier Hospital Sutton
Carshalton and Wallington MP Mr Dean slammed these delays, pointing out the Trust's infrastructure is struggling under the pressure of outdated facilities.
He said: 'Delays to the promised St Helier upgrades directly threaten the future of our hospital and leave patients and NHS staff paying the price.
"The queues to get emergency treatment are spiralling across the country, but the poor state of our buildings is making the situation even worse.'
Bobby Dean MP
In 2019, the then-Boris Johnson-led government promised £500 million for Sutton as part of the nationwide New Hospital Programme (NHP).
The estimated cost now, though, is between £1.5 billion and £2 billion. The NHP promised to build 40 new hospitals by 2030.
However, the current Labour government have since dismissed Mr Johnson's plans as 'a work of fiction'.
As a result, vital upgrades have been pushed back to the 2030s, leaving the future of St Helier Hospital hanging in the balance.
The hospital's ageing infrastructure has exacerbated the strain, leaving the community to suffer while vital upgrades remain delayed.
Mr Dean warned the delays to upgrades threaten the hospital's future, leaving both patients and NHS staff bearing the brunt.
He described the growing queues for emergency care as a national crisis but added that the poor condition of hospital buildings is making the situation even worse.
The local MP shared a personal experience of the crisis, recounting how an elderly relative had to wait on the floor in A&E due to a shortage of trolleys and beds.
'The government must see sense and urgently bring forward these long-overdue upgrades,' Mr Dean said.
In response, a spokesperson for Epsom and St Helier University Hospitals NHS Trust told the Local Democracy Reporting Service: 'While patients in our emergency department are kept safe and we prioritise those who are the sickest, we don't want to be providing care in this way and apologise to anyone experiencing long waits as our teams continue to do the best they can under huge pressure.
'We've been very busy, driven by a surge in viruses such as flu and norovirus – people can help us by using NHS 111, their GP or a pharmacy if their need is less urgent, and by getting their jabs.'
The trust has spent £60 million over the past five years improving its facilities but admitted its ageing hospitals are deteriorating faster than they can be fixed. They added that while construction of a new hospital and upgrades to existing sites will now begin later than planned, patient safety remains the trust's top priority.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
an hour ago
- Yahoo
Resident doctors strike in the face of a tiring public
Up to 50,000 NHS resident doctors are currently on strike over pay, their twelfth walkout since March 2023. So what? This month Labour announced an ambitious plan meant to revive a health service that is on its knees. Any detail from that has now been overtaken by a downing of tools that will severely disrupt medical treatments; could encourage similar action by nurses; and may lead to patient deaths. Here we go again. Ending resident doctor strikes was one of the health secretary Wes Streeting's first priorities. Last year he struck a deal with the British Medical Association to increase pay by 22 per cent. This was a temporary boost, since it only applied to 2023-25 salaries. For 2025-26, the rise was 5.4 per cent. Not good enough. This is better than the 3.6 per cent pay rise awarded to nurses in June 2025. But the BMA wants full 'pay restoration'. It says the salaries of resident doctors, who are still in training, are 21 per cent lower in real terms than in 2008 because of inflation. Damned statistics. The BMA uses the Retail Price Index (RPI) to reach this number. The government uses another measure, the Consumer Price Index (CPI). This is the official metric used to calculate changes to the cost of living, based on a basket of consumer goods. If CPI is used, pay has only fallen by 4.7 per cent since 2008, according to the Nuffield Trust. Hang on. The BMA's insistence on using RPI is based, in part, on the fact that the government uses it to calculate rail fares and interest payments on student debt. The latter is particularly relevant. Although they earn a relatively high salary after 5 years in training (£61,825 a year, excluding compulsory overtime), doctors emerge from five years of medical school owing as much as £100,000. Ouch. That's nearly double the average debt pile of British graduates. Unlike many other professionals, medical trainees also spend thousands of pounds on exam fees and courses. Another thing. Pay isn't the only grievance, with resident doctors also complaining about a shortage of speciality training posts, which means many get stuck on the middle rungs of the career ladder; an arcane placement system that requires them to move around the country at a few months' notice; and gruelling hours and stressful working conditions. Cash-strapped. This time round, the health secretary is less sympathetic and says there is no more money for pay rises. Last year's increases ate up more than half of the extra £10.4 billion given to the NHS. Streeting would rather be getting on with plans to revamp the health system. These are centred around shifting care from hospitals to the community; making better use of digital tech; and preventing sickness in the first place. Shifting opinions. The public seems to be on his side. In 2024, more than half of Brits supported strike action by trainee doctors. This has fallen to 32 per cent. The head of the Royal College of Nursing has said it is 'grotesque' to hand doctors bigger increases than nurses. Negotiations. In an unsuccessful bid to avert the strikes, Streeting made several last-minute offers, including accelerating doctors' training so they progress through the pay scales faster; giving them part of their pensions upfront; and subsidising exam fees. The toll. Previous rounds of strikes led to the cancellation of 1.5 million planned appointments, as well as five deaths. Labour is eager to avert more cancellations, having made much of bringing down waiting lists. NHS England has not postponed scheduled non-urgent care. What's more… The BMA has criticised this decision, saying it puts lives at risk. Critics have pinned the responsibility on them, saying they chose to strike. Either way, patients will suffer.
Yahoo
5 hours ago
- Yahoo
Pharmacy warning of unsustainable demand for weight loss medication
The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Yahoo
5 hours ago
- Yahoo
Pharmacies warn of unsustainable demand for weight loss medication
The booming demand for weight loss jabs may be unsustainable, pharmacists warn. Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'